Cannabis Law Report

FEBRUARY 14, 2020

a Canadian biotech firm, is entering Phase II clinical trials for two experimental treatments. According to its website, one trial involves an ibogaine-derived drug for treating opioid addiction. The other trial will test LSD microdosing as an ADHD treatment. Mind Medicine, Inc. ,

Microdosing 45

Microdosing Treatment Medicine Clinical Trials 45

Cannabis Law Report

MAY 10, 2023

However, a company may be in possession of the most healing psychedelic compound in the world, but unless they can prove it through the clinical trial process, their superior medicine will mean little. Yes, of course, it matters greatly who has the most effective medical psychedelic molecule in specific circumstances.

Microdosing 52

Microdosing Medicine Clinical Trials 52

Cannabis Law Report

DECEMBER 2, 2021

(IGC) is excited to present preliminary positive secondary end point findings from its Phase 1 clinical trial for IGC-AD1. The results of the clinical trial have been submitted in the Clinical/Statistical Report (“CSR”) filed with the FDA, and relevant data is also available on Form 8-K filed with the SEC on December 2, 2021.

Clinical Trials 40

Clinical Trials Data Patients THC 40

Miss Marijuana

JANUARY 30, 2025

But here’s something interesting: a recent study from 2024 showed that 78% of people using medical cannabis saw a major drop in anxiety within just a month! While prescription meds have been the go-to for a long time, more and more people are turning to cannabis as a natural alternative. Let’s dive in and explore! And the best part?

Treatment 52

Treatment Microdosing Indica Terpenes 52

Veriheal

MARCH 20, 2023

Using psilocybin in small doses, or microdosing, has been shown to aid in the treatment of various mental health issues, including anxiety, depression, PTSD, and obsessive-compulsive disorder. Smith cited results from clinical trials showing that MDMA holds promise in the treatment of PTSD. appeared first on Cannabis Central.

Clinical Trials 98

Clinical Trials Therapy Decriminalization Treatment 98

Cannabis Law Report

JULY 13, 2022

“Their position as therapeutic practitioners, as well as their work in conducting the kind of clinical trials necessary to advance regulatory outcomes for psychedelic medicines, make them ideal partners in alignment with Optimi’s strategic goals.”.

Therapy 52

Therapy Clinical Trials Microdosing Research and Development 52

Cannabis Law Report

JUNE 19, 2022

The market for psychedelic substances is projected to grow rapidly, potentially outpacing the legal US cannabis market. For example, compounds such as psilocybin, mescaline, ibogaine, and LSD are being evaluated in clinical trials, but the compounds themselves are unpatentable because their existence is well documented in the prior art.

Clinical Trials 52

Clinical Trials Microdosing Data Pharmaceutical 52

Cannabis Law Report

AUGUST 10, 2022

According to CAMH’s lead investigator, clinical trials suggest that psilocybin, combined with psychotherapy, can produce “ sustained antidepressant effects” in individuals living with severe depression.

Clinical Trials 52

Clinical Trials Research and Development Therapy Microdosing 52

The Cannigma

JUNE 24, 2021

Hemp and cannabis-derived medications may not be quite as mainstream as apple pie or multivitamins, but the days in which it was an almost completely illegal plant with little if any recognized medical benefits seem like a distant memory. These natural alternatives may also be effective as part of a daily “microdosing” regiment.

CBD 105

CBD Microdosing Edibles Sleep 105

Cannabis Law Report

MAY 12, 2022

Microdose report. What are the gaps in current psychedelic research, including questions about the methods of current clinical trials and other key scientific questions that need to be addressed to further our understanding of psychedelics? If not, would you initiate such a review?

Research and Development 52

Research and Development Clinical Trials Microdosing Food 52

Cannabis Law Report

FEBRUARY 10, 2022

A look at key research and clinical trials that were published in 2021, with analysis of themes like microdosing and SSRI interactions. The report includes: A deep dive into psychedelic drug policy reform efforts and successes in 2021, with a focus on key jurisdictions including the U.S. and Canada.

Clinical Trials 52

Clinical Trials Microdosing Pharmaceutical Policy 52

LifeCannMD

MAY 27, 2025

Then this cannabis strain came alongone that would eventually carry her name and completely flip the medical world upside down. Your Body Already Knows How to Work with Cannabis (Seriously!) Here’s something that blows most of my patients’ minds: your body actually has built-in receptors for cannabis compounds.

CBD 52

CBD Oil Epilepsy Sleep 52

Cannabis Law Report

MARCH 3, 2022

The team at Microdose, the world’s biggest medical psychedelic conference , said the country’s move to permit Med Plant Science Ltd to produce psychedelic compounds makes it the first country to legalize all psychedelic medicine. . The eventual trials would target PTSD, addiction, alcoholism, depression, and anxiety. and Europe.

Research and Development 52

Research and Development Medicine Clinical Trials Microdosing 52

Cannabis Law Report

FEBRUARY 9, 2022

They can’t add alcohol, cannabis, or anything that might alter the potency or make psilocybin potentially addictive. The draft rules share some similarities with Oregon’s cannabis rules. For example, there’s a desire among some people to microdose psilocybin, that is taking very small amounts every few days.

Clinical Trials 52

Clinical Trials Microdosing Safety Conditions 52

Cannabis Law Report

NOVEMBER 24, 2019

The growth and management of psychedelics regulation will be equally chaotic, but we think just as fast as the cannabis sector. Dr. Johnson recently spoke about microdosing and its affects on creativity. Announcing the Center for Psychedelic and Consciousness Research. Participate in Our Studies. ANOREXIA NERVOSA. ALZHEIMER’S DISEASE.

Therapy 59

Therapy Treatment Medicine Clinical Trials 59

The Cannigma

DECEMBER 12, 2022

What is microdosing? A microdose is a dose that does not elicit a perceivable intoxicating or trip-like effect. At most, a mood boost should be all that is felt, and if any visual or auditory effects are noticeable then the dose is not, by definition, a microdose. Everyone is different.

History 141

History Microdosing Research and Development Clinical Trials 141

Cannabis Law Report

JULY 9, 2022

Desperate to find any solution, she tried microdosing psilocybin mushrooms after researching the practice online. For Thornton, however, microdosing psilocybin mushrooms was a question of life or death. “I I decided to try microdosing psilocybin for depression because nothing else was working for me,” explains Thornton. “I

Microdosing 52

Microdosing Wellness and Beauty Research and Development Clinical Trials 52

Canna Law Blog

NOVEMBER 15, 2021

Microdose hosted its annual psychedelics conference in Miami last week (appropriately titled “Wonderland”). Some of these companies are already engaged in clinical trials , a key indicator that significant capital and resources are behind entrants into the market. Psychedelics are not cannabis.

Clinical Trials 98

Clinical Trials Treatment Microdosing Pharmaceutical 98

Cannabis Law Report

SEPTEMBER 10, 2019

Forbes reported on Hopkins researchers’ recommendation that, if psilocybin should clear Phase III clinical trials, the FDA should reclassify it from a Schedule I to a Schedule IV drug. Garcia-Romeu Comments on Recent Study of Psychedelic Microdosing in Rats. What It’s Like to Smoke Salvia for Science.

Research and Development 45

Research and Development Microdosing Clinical Trials Decriminalization 45

CannaMD

OCTOBER 7, 2019

As leading researchers summarize: The effect size of cannabis use on body mass index (BMI) is large and the magnitude of the difference in BMI of users and non-users is of clinical significance. Head on over to our appointment page to get started with medical cannabis today! Already know that medical marijuana is right for you?

Marijuana 107

Marijuana Cannabinoids Patients Conditions 107

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. a leading biotech company in the hemp and cannabis industries. Rick Doblin, Ph.D, in/rickdoblin/ [link]. in/ronanlevy/. Shlomi Raz.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51